Prof. Willbold´s interview with PharmaVentures - priavoid.com

Prof. Willbold´s interview with PharmaVentures

November 14th, 2017

Düsseldorf-Jülich Symposium on Neurodegenera7ve Diseases 2017 Bildquelle: Fotolia

Prof. Dieter Willbold talks with Summer Park of PharmaVentures at Biotech and Money Investival, London in 2017.

News & Events:

Funding from The Michael J. Fox Foundation

Funding from The Michael J. Fox Foundation

24. Februar 2021

Priavoid closes financing round

Priavoid closes financing round

12. Februar 2021

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

11. Februar 2021

Alzheimer´s Research: Important Milestone for PRI-002

Alzheimer´s Research: Important Milestone for PRI-002

4. Februar 2021

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

9. Dezember 2020

New CEO of Priavoid

New CEO of Priavoid

2. September 2020

Priavoid Headquarters at LSC Düsseldorf

Priavoid Headquarters at LSC Düsseldorf

6. März 2020

Seed Investment

Seed Investment

6. Mai 2019

Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018

Clinical trial with PRI-002

Clinical trial with PRI-002

31. Mai 2017